StemCell Therapy

Biotechnology: One of the Bay Area's Top Growth Industries

The Bay Area is a leader in the global biopharmaceutical industry, with local companies and research institutions setting the pace in the discovery and development of biopharmaceuticals to target major unmet medical conditions, such as cardiovascular disease, cancer, AIDS and other degenerative diseases.

UCSC Extensions Biotechnology Certificate provides a solid understanding of the scientific disciplines that underlie the industrys activities, a foundation in the principles that guide drug discovery and development, an appreciation of cutting-edge bioscience research and technology, and a broader awareness of todays biopharmaceutical industry. This combination of general and practical knowledge enhances the skills of professionals currently working in this industry and helps prepare others to enter this dynamic field.

This program is designed for chemists, biologists and other scientists who want to enhance their knowledge of the principles and applications of biotechnology. It also benefits individuals from other disciplines who need a solid scientific foundation in order to enter or work more effectively in the biopharmaceutical field.

Continued here:
Biotechnology | UCSC Extension Silicon Valley

Arthritis is very common but is not well understood. Actually, arthritis is not a single disease; it is an informal way of referring to joint pain or joint disease. There are more than 100 differenttypes of arthritis and related conditions. People of all ages, sexes and races can and do have arthritis, and it is the leading cause of disability in America. More than 50million adults and 300,000 children have some type of arthritis. It is most common among women and occurs more frequently as people get older.

Common arthritis jointsymptomsinclude swelling, pain, stiffness and decreased range of motion. Symptoms may come and go. They can be mild, moderate or severe. They may stay about the same for years, but may progress or get worse over time. Severe arthritis can result in chronic pain, inability to do daily activities and make it difficult to walk or climb stairs. Arthritis can cause permanent joint changes. These changes may be visible, such as knobby finger joints, but often the damage can only be seen on X-ray. Some types of arthritis also affect the heart, eyes, lungs, kidneys and skin as well as the joints.

There are different types of arthritis:

Osteoarthritisis the most common type of arthritis. When the cartilage the slick, cushioning surface on the ends of bones wears away, bone rubs against bone, causing pain, swelling and stiffness. Over time, joints can lose strength and pain may become chronic. Risk factors include excess weight, family history, age and previous injury (an anterior cruciate ligament, or ACL, tear, for example).

When the joint symptoms of osteoarthritis are mild or moderate, they can be managed by:

balancing activity with rest

using hot and cold therapies

regular physical activity

maintaining a healthy weight

strengthening the muscles around the joint for added support

using assistive devices

taking over-the-counter (OTC) pain relievers or anti-inflammatory medicines

avoiding excessive repetitive movements

If joint symptoms are severe, causing limited mobility and affecting quality of life, some of the above management strategies may be helpful, but joint replacement may be necessary.

Osteoarthritis can prevented by staying active, maintaining a healthy weight, and avoiding injury and repetitive movements.

A healthy immune system is protective. It generates internal inflammation to get rid of infection and prevent disease. But the immune system can go awry, mistakenly attacking the joints with uncontrolled inflammation, potentially causing joint erosion and may damage internal organs, eyes and other parts of the body. Rheumatoid arthritis and psoriatic arthritis are examples of inflammatory arthritis. Researchers believe that a combination of genetics and environmental factors can trigger autoimmunity. Smoking is an example of an environmental risk factor that can trigger rheumatoid arthritis in people with certain genes.

With autoimmune and inflammatory types of arthritis, early diagnosis and aggressive treatment is critical. Slowing disease activity can help minimize or even prevent permanent joint damage. Remission is the goal and may be achieved through the use of one or more medications known as disease-modifying antirheumatic drugs (DMARDs). The goal of treatment is to reduce pain, improve function, and prevent further joint damage.

A bacterium, virus or fungus can enter the joint and trigger inflammation. Examples of organisms that can infect joints are salmonella and shigella (food poisoning or contamination), chlamydia and gonorrhea (sexually transmitted diseases) and hepatitis C (a blood-to-blood infection, often through shared needles or transfusions). In many cases, timely treatment with antibiotics may clear the joint infection, but sometimes the arthritis becomes chronic.

Uric acid is formed as the body breaks down purines, a substance found in human cells and in many foods. Some people have high levels of uric acid because they naturally produce more than is needed or the body cant get rid of the uric acid quickly enough. In some people the uric acid builds up and forms needle-like crystals in the joint, resulting in sudden spikes of extreme joint pain, or a gout attack. Gout can come and go in episodes or, if uric acid levels arent reduced, it can become chronic, causing ongoing pain and disability.

Diagnosing Arthritis

Arthritis diagnosis often begins with a primary care physician, who performs a physical exam and may do blood tests and imaging scans to help determine the type of arthritis. An arthritis specialist, or rheumatologist, should be involved if the diagnosis is uncertain or if the arthritis may be inflammatory. Rheumatologists typically manage ongoing treatment for inflammatory arthritis, gout and other complicated cases. Orthopaedic surgeons do joint surgery, including joint replacements. When the arthritis affects other body systems or parts, other specialists, such as ophthalmologists, dermatologists or dentists, may also be included in the health care team.

What Can Be Done About Arthritis?

There are many things that can be done to preserve joint function, mobility and quality of life. Learning about the disease and treatment options, making time for physical activity and maintaining a healthy weight are essential. Arthritis is a commonly misunderstood disease. The Arthritis Foundation is the only nonprofit organization dedicated to serving all people with arthritis. Its website, arthritis.org, has many resources for learning about arthritis, practical tips for daily living and more.

View post:
What Is Arthritis?

Conference Series LLCinvites all the participants from all over the world to attend 10th International Conference on Nanomedicine and Nanotechnology in Health Care during July 25-27, 2016 at Avani Atrium, Bangkok, Thailand. It will include presentations and discussions to help attendees address the current trends and research on the applications of Nanomedicine and nanotechnology in healthcare. The theme of the conference is "Embarking Next Generation Delivery Vehicles for affordable Healthcare!"

Nanomedicineis innovating the healthcare industry and impacting our society, but is still in its infancy in clinical performance and applications. The aim of thisNanomedicine 2016conference is to bring together leading academic, clinical and industrial experts to discuss development of innovative cutting-edge Nanomedicine and challenges in Nanomedicine clinical translation.

Track 01:Nanomedicine

Nanomedicine applications in the field of medicine are vast. It helps in the detection, diagnosis, prevention, treatment and follow-up of many diseases.Personalized Nanomedicineis being applied in all the branches of medicine like Radiology, Neurology, Surgery, Pulmonology, Dentistry, Orthopaedics, Ophthalmology etc.Nanomedicine conferencesfocusses on how Nanomedicine can be the next delivery vehicle for making healthcare affordable.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting

Nanomaterials Conference April 21-23 2016, UAE; MedicalNanotechnologySummit June 9-11 2016, Dallas; Molecular Nanoscience Meeting September 26-28 2016, UK; Nanotechnology Expo November 10-12 2016, Australia; Nanotech Expo December 5-7 2016, USA; International Conference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; International Conference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; International Conference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting and Expo onNanomaterialsand Nanotechnology, 25th - 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece, American Society For Nanomedicine, Washington, USA, Society for Personalized Nanomedicine, Florida, USA

Track 02: Nanomedicine and Drug delivery

There are a many ways thatnanotechnologycan make the delivery of drugs more systematic and accost effective treatment for the patient. Numerous biological materials like albumin, gelatine and phospholipids for liposomes, and more substances of a chemical nature like various polymers and solid metal containing nanoparticles are under investigation for preparation of nanoparticles. The hazards that are introduced by usingnanoparticles for drug deliveryare more than that posed by conventional hazards imposed by chemical delivery.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Bioavailability and Bioequivalence Summit August 29-31, 2016, USA;Surgical OncologyConference during September 01-03, 2016, Brazil; Precision Medicine ConferenceNovember 03-05, 2016, USA; Translational MedicineConference November 17-19, 2016, USA;Mesothelioma Summit,November 03-04, 2016, Spain; International Conference onBiotechnologyand Nanotechnology, April 14-15, 2016, Portugal;Nanotech Conference & Exhibition, 01-03 June, 2016, France; Materials Scienceand Nanotechnology Conference July 28- 29, 2016, China; 7thInternationalnanotechnology Summit: fundamentals and applications, August 19-10, 2016 Hungary, Society for Personalized Nanomedicine, Florida, USA, European Society for Nanomedicine, Basel, Switzerland

Track 03:Nanomedicine and Nanotechnology

Nanomedicine is an emerging specialty born from Nanotechnology. Bothnanomedicine and nanotechnologyare emerging as the new direction in the diagnosis and drug therapy. Nanomedicine can change the face of healthcare in the future using nanotechnology.Nanomedicinehelps detect, repair, understand and control the human biological system. Nanomedicine can be used forpersonalized Nanomedicine.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Nanomaterials Conference April 21-23 2016, UAE; MedicalNanotechnologySummit June 9-11 2016, Dallas; Molecular Nanoscience Meeting September 26-28 2016, UK; Nanotechnology Expo November 10-12 2016, Australia; Nanotech Expo December 5-7 2016, USA; International Conference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; International Conference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic, Biotechnology, Bioengineering andNanoengineering Conference, April 14-15, 2016, Portugal; Nanomaterials Conferenceand Nanotechnology, 25th - 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece, International Association of Nanotechnology, California, USA, French Society for Nanomedicine, Lille, France

Track 04:Nanomedicine and Nanobiotechnology

Nanobiotechnologyis the intersection of nanotechnology and biology. Nanobiotechnology has multitude of potentials for advancing medical science thereby improving health care practices around the world. Nanomedicine is used to treat diseases bygene therapy. Nano biotechnologies are being applied to molecular diagnostics and several technologies are in development.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

NanoConference June 20-21, 2016 Cape Town, South Africa; Medical NanotechnologyCongress and Expo June 9-11, 2016 Dallas, USA; Nanotechnology Congress June 27-29, 2016 Valencia, Spain; 11th Nanobiotechnology MeetingSeptember 26-28, 2016 London, UK: Nanotechnology Expo November 10-12, 2016 Melbourne, Australia: International Conference on NanotechnologyModellingand Simulation April 1-2, 2016 Prague, Czech Republic: The 5th Conference onNanomaterialsJanuary 14-16, 2016 Bangkok, Thailand: Nanotechnology Conference and Expo Baltimore, USA, 4th to 6th April 2016: 4thNanoscience Conference (ICNT2016) Kuala Lumpur, Malaysia, 28th - 29th January 2016: 4th Conference on Materials ScienceNew York, USA, American Nano Society, Florida, USA, Sustainable Nanotechnology Organization, Washington, USA

Track 05:Nanomedicine and Bioengineering

Nanomedicinehas a considerable role in Bioengineering. To design and construct an apt scaffold is the major challenge inRegenerative medicinetoday. The cell-cell and cell-matrix interactions in the biosystems happen at the nanoscale level. Therefore the application of nanotechnology at that level helps in modifying the cellular function to mimic the native tissue in a more appropriate way. The application ofBioengineeringhas transformed the designing the manufacturing of scaffolds and artificial grafts.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Stem Cell Research conference February 29-March 02 2016, USA, Bio banking ConferenceAugust 18-19 2016, USA; Regenerative Medicine Conference,September 12-14 2016, Germany; 6th Pharmacogenomics ConferenceSeptember 12-14, 2016, Berlin, Germany; Conference onRestorative MedicineOctober 24-26, 2016, USA ; Conference onRegeneration, January 10 14, 2016, USA; ISSCR Conference onNeural Degenerationand Disease, 18th Biotechnology Meeting, April 11-12, 2016, Italy; 14th European Symposium on Drug Delivery, 13th-15thApril 2016, The Netherlands Sustainable Nanotechnology Organization, Washington, USA, Asian Nanoscience and Nanotechnology Association, Kagawa, Japan

Track 06:Nanomedicine and Cancer

Cancer Nanomedicineaims to use the nanostructures and nanoscale processes for the prevention, detection, diagnosis and treatment of cancer and other concomitant areas. Even when molecular changes occur in a smaller percentage of cells, which may be cancer related targets.Nanomedicine in cancercan help in the sensitive detection of them. The use of Nanotechnology to combat cancer is still under development. Severalnanocarrierdrugs andnanotherapeuticsare available in market and some in Clinical trials.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

CancerDiagnostics Expo June 13-15 2016, Italy; Conference onCancer Immunologyand Immunotherapy July 28-30 2016, Australia;Cancer GenomicsSummit August 8-9 2016, USA; 12th Cancer TherapySummit September 26-28 2016, UK; International Conference onCervical CancerSeptember 22-23 2016, Austria; TheBiomarkerConference, 18th-19th February 2016, USA; Cancer Vaccines: Targeting Cancer Genes forImmunotherapy, March 610 2016, Canada; 18th Conference on Biotechnology Advances, April 11-12, 2016, Italy; 14th European Drug Delivery Summit, April 13-15 2016, The Netherlands; 18th InternationalCancer NanomedicineConference and Novel Drug Delivery Systems, April 22 - 23, 2016, United Kingdom, Asian Nanoscience and Nanotechnology Association, Kagawa, Japan, European Nanoscience and Nanotechnology Association, Bulgaria.

Track 07:Nanomedicine and Healthcare

Nanomedicineaffects almost all the aspects of healthcare. Nanomedicine helps to engineer novel and advanced tools for the treatment of various diseases and the improvement of human biosystems usingmolecular Nanotechnology. Cardiovascular diseases, Neurodegenerative disorders, Cancer, Diabetes, Infectious diseases, HIV/AIDS are the main diseases whose treatment can be benefitted by using nanomedicine.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Bioequivalence and Bioavailability Summit August 29-31, 2016, USA;Surgical OncologyConference during September 01-03, 2016, Brazil; Precision Medicine ConferenceNovember 03-05, 2016, USA; Translational MedicineConference November 17-19, 2016, USA;Mesothelioma Summit,November 03-04, 2016, Spain; International Conference onBiotechnologyand Nanotechnology, April 14-15, 2016, Portugal;Nanotech Conference & Exhibition, 01-03 June, 2016, France; Materials Scienceand Nanotechnology Conference July 28- 29, 2016, China; 7thInternationalnanotechnology Summit: fundamentals and applications, August 19-10, 2016 Hungary, Society for Personalized Nanomedicine, Florida, USA, European Society for Nanomedicine, Basel, Switzerland

Track 08:Nanomedicine and Healthcare Applications

Nanomedicineapplications in healthcare Industry are broad. It helps to engineer newNano medical devices, design nanoparticles for detection and drug delivery in cancer. Nanomedicine can be applied in allied areas of healthcare like Wound healing, Food Industry and Hair growth. Nanomedicine is being widely used forpublic health and Nutrition.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

NanoConference June 20-21, 2016 Cape Town, South Africa; Medical NanotechnologyCongress and Expo June 9-11, 2016 Dallas, USA; Nanotechnology Congress June 27-29, 2016 Valencia, Spain; 11th Nanobiotechnology MeetingSeptember 26-28, 2016 London, UK: Nanotechnology Expo November 10-12, 2016 Melbourne, Australia; International Conference on NanotechnologyModellingand Simulation April 1-2, 2016 Prague, Czech Republic: The 5th Conference onNanomaterialsJanuary 14-16, 2016 Bangkok, Thailand: Nanotechnology Conference and Expo Baltimore, USA, 4th to 6th April 2016: 4thNanoscience Conference (ICNT2016) Kuala Lumpur, Malaysia, 28th - 29th January 2016: 4th Conference on Materials ScienceNew York, USA, American Nano Society, Florida, USA, Sustainable Nanotechnology Organization, Washington, USA.

Track 09: Nanotechnology and Food

Nanotechnology has begun to find potential applications in the area of functional food by engineering biological molecules toward functions very different from those they have in nature, opening up a whole new area of research and development. Of course, there seems to be no limit to whatfood technologistsare prepared to do to our food and nanotechnology will give them a whole new set of tools to go to new extremes. Nanotechnology may revolutionize the food industry by providing stronger, high-barrier packaging materials, more potent antimicrobial agents, and a host of sensors which can detect trace contaminants, gasses or microbes in packaged foods.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Biopolymers Congress, August 01-03, 2016, UK; Conference onSustainable BioplasticsNovember 10-12, 2016, Spain; Biopolymers andBioplastics Summit, September 12-14, 2016, USA; Biofuelsand Bioenergy September 1-3, 2016, Brazil; Public HealthSummit March 10-12, 2016, Spain; 5th Annual PharmaceuticalMicrobiology Conference, 2021 January 2016, United Kingdom; 18th International Conference on Biomaterials,Colloidsand Nanomedicine, January 21-22, 2016, France; 13th National Conference and Technology Exhibition On Medical Devices &PlasticsDisposables, February 12-13, 2016, USA; 18th International Conference onToxicology, February 25 - 26, 2016; United Kingdom; Faraday Discussion:Nanoparticleswith Morphological and Functional Anisotropy, 46 July 2016, United Kingdom, Asian Nanoscience and Nanotechnology Association, Kagawa, Japan, European Nanoscience and Nanotechnology Association, Bulgaria

Track 10:Nanomedicine and Nanotheranostics

Nanotheranosticscombine both the Non-invasive diagnosis and treatment of diseases and helps to monitor the drug release and dispersion of the drug, thereby increasing the effectiveness of therapy.Cancer nanotheranosticshold a great promise in improving the treatment outcomes in Cancer. Nanotheranostics are currently being used in theBiomarker Discovery. Nanotheranostics include both Genomics based theranostics and Proteomics based theranostics

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Pharmacology SummitAugust 08-10 2016, UK;Conference onClinical TrialsAugust 22-24 2016, USA; Neuropharmacology MeetingSeptember 15-17 2016, USA;PharmacovigilanceSummit September 19-21 2016 in Austria; Drug DiscoveryExpo October 24-26 2016, Turkey; 18th International Conference onBioengineering, Biotechnology and Nanotechnology, January 18 - 19, 2016, United Kingdom; 4thImmunogenicity& Immunotoxicity Conference January 25-26, 2016, USA; Genomics andpersonalized medicine conference, 07-11 February, 2016, Canada;Conference onAntibodiesas Drugs, 06-10 March, 2016, Canada; Pharmaceutical Sciences Congress, 28 August - 1 September 2016, Argentina, American Society For Nanomedicine , Washington, USA, Society for Personalized Nanomedicine, Florida, USA

Track 11: Nanomedicine and Nanobiology

Nano biologyis the branch where basic biology of the organism and nanotechnology meet. Nano biology helps in addressing the basic mechanisms of human health and diseases at the cellular and molecular level.Nano biologyapplied in microbiology is Nanomicrobiology. Recently certain nanoparticles are being designed to act against infections

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Conference onPharmaceutics March 07-09 2016, Spain; BiosimilarsCongress June 27-29, 2016 Valencia, Spain; Drug DeliverySummit June 30- July 02 2016, USA; Conference onPharmaceuticalRegulatory Affairs and IPR September 12-14 2016, USA; Asia Pacific MassSpectrometryCongress October 10-12 2016, Malaysia;Advanced MaterialsConference (IC2NAM), January 15th 2016; New Zealand; Modern PhenotypicDrug Discovery Summit: Defining the Path Forward, April 26, 2016; USA; 10th IEEE international Conference on Molecular Medicineand Engineering, 17-20 April 2016, Japan; 2ndDrug Delivery Meeting: Advanced Mechanisms & Product Design, May 18-19, 2016, 2016; 6th International Conference on Manipulation, Manufacturing and Measurement on theNanoscale, 18-22 July 2016, China, International Association of Nanotechnology, California, USA, French Society for Nanomedicine, Lille, France, , Asian Nanoscience and Nanotechnology Association, Kagawa, Japan, European Nanoscience and Nanotechnology Association, Bulgaria

Track 12:Nanomedicine and Nanopharmaceuticals

Nanopharmaceuticalssuch as liposomes,quantum dots, dendrimers,carbon nanotubesand polymeric nanoparticles have brought considerable changes in drug delivery and the medical system. Nanopharmaceuticals offer a great benefit for the patients in comparison with the conventional drugs. There are several advantages of these drugs such as enhanced oral bioavailability, improved dose proportionality, enhanced solubility and dissolution rate, suitability for administration and reduced food effects.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Conference onPharmaceutics March 07-09 2016, Spain; BiosimilarsCongress June 27-29, 2016 Valencia, Spain; Drug DeliverySummit June 30- July 02 2016, USA; Conference onRegulatory Affairs and IPR September 12-14 2016, USA; Asia Pacific MassSpectrometryCongress October 10-12 2016, Malaysia;Advanced MaterialsConference (IC2NAM), January 15th 2016; New Zealand; Modern PhenotypicDrug Discovery: Defining the Path Forward, April 26, 2016; USA; 10th IEEE international Conference on Molecular Medicineand Engineering, 17-20 April 2016, Japan; 2ndDrug Delivery Meeting: Advanced Mechanisms & Product Design, May 18-19, 2016, 2016; 6th International Conference on Manipulation, Manufacturing and Measurement on theNanoscale, 18-22 July 2016, China, International Association of Nanotechnology, California, USA, French Society for Nanomedicine, Lille, France.

Track 13:Nanomedicine and Nanotoxicology

Nanotoxicologyis intended to address the toxicological activities of nanoparticles and their products to determine whether and what extent they may pose a threat to the environment and to human health and defined as the study of the nature and mechanism of toxic effects of nanoscale materials/particles on living organisms and other biological systems. It also deals with the quantitative assessment of the severity and frequency of nanotoxic effects in relation to the exposure of the organisms. The knowledge from nanotoxicology study will be the base for designing safenanomaterialsandnanoproducts,and also direct used innanomedicalsciences.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Pharmacology andEthnopharmacology Conference May 02-04 2016, USA; Conference on Toxicogenomics June 09-10 2016, USA; Environmental ToxicologySummit August 25-26 2016, Brazil; BiosimilarsCongress September 12-14, 2016 USA; ToxicologySummit October 27-29 2016, Italy;Biosimilarsand Biologics Congress 1-2 February, 2016, Germany; The Oxford ChemicalImmunologyConference, 45 April 2016, United Kingdom; Toxicology and risk assessment conference, April 4-6, 2016; USA; 18th International Conference onBioinformaticsand Bioengineering, April 25-16, 2016, France; Toxicology Meeting, September 47, 2016, Turkey, Society for Personalized Nanomedicine, Florida, USA, European Society for Nanomedicine, Basel, Switzerland

Track 14:Nanomedicine and Nanomedical Devices

Nanomedical devicesshow great promise in various applications for health care. Many nano scale devices have already been approved by the FDA. Nano scale materials can be used as delivery mechanisms allowing cells to absorb therapeutics into the cell wall. Various nano materials are being researched for use in cancer therapeutics.Nanowiresand needles are being researched and developed for use in epilepsy and heart control.Nanosized surgical instrumentscan be used to perform microsurgeriesand better visualization of surgery.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Generic Drug Market Expo Oct 31- Nov 02 2016, Spain; Medical Devices Expo December 1-3 2016, USA; African Surgical and Medical Devices Expo June 20-21, 2016, South Africa; Conference on Biomaterials March 14-16 2016, UK; Bioavailability & Bioequivalence Summit August 29-31 2016, USA; Microbiology Summit, 2021 January 2016, United Kingdom; 18th International Conference on Biomaterials, Colloids and Nanomedicine, January 21-22, 2016, France; 13th Medical Devices Exhibition & Plastics Disposables, February 12-13, 2016, USA; 18th International Conference on Toxicology, February 25 - 26, 2016; United Kingdom; Faraday Discussion: Nanoparticles with Morphological and Functional Anisotropy, 46 July 2016, United Kingdom, International Association of Nanotechnology, California, USA, French Society for Nanomedicine, Lille, France

Track 15:Nanomedicine and Nanodiagnostics

The use of Nanotechnology in clinical diagnosis is termed asNano diagnostics. Diagnosis at the single cell level or molecular level can be possible through Nano diagnostics. They can even be incorporated even in the current diagnostic methods like Biochips.Nanobiosensorsare promising devices for Clinical applications.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Bioavailability and Bioequivalence Summit August 29-31, 2016, USA;Surgical OncologyConference during September 01-03, 2016, Brazil; Precision Medicine ConferenceNovember 03-05, 2016, USA; Translational MedicineConference November 17-19, 2016, USA;Mesothelioma Summit,November 03-04, 2016, Spain; International Conference onBiotechnologyand Nanotechnology, April 14-15, 2016, Portugal;Nanotech Conference & Exhibition, 01-03 June, 2016, France; Materials Scienceand Nanotechnology Conference July 28- 29, 2016, China; 7thInternationalnanotechnology Summit: fundamentals and applications, August 19-10, 2016 Hungary, Society for Personalized Nanomedicine, Florida, USA, European Society for Nanomedicine, Basel, Switzerland.

Track 15:Nanoethics and Regulations

Nanoethicsis the study ethical and social implications of nanotechnologys. It is an emerging but controversial field.Nanoethics is a debatable field.As the research is increasing on nanomedicine, there are certain regulations to increase their efficacy and address the associated safety issues. Other issues in nanoethics include areas likeresearch ethics, environment,global equity, economics, politics, national security, education, life extension and space exploration.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Generic Drug Market Expo Oct 31- Nov 02 2016, Spain; Medical Devices Expo December 1-3 2016, USA; African Surgical and Medical Devices Expo June 20-21, 2016, South Africa; Conference on Biomaterials March 14-16 2016, UK; Bioavailability & Bioequivalence Summit August 29-31 2016, USA; Microbiology Summit, 2021 January 2016, United Kingdom; 18th International Conference on Biomaterials, Colloids and Nanomedicine, January 21-22, 2016, France; 13th Medical Devices Exhibition & Plastics Disposables, February 12-13, 2016, USA; 18th International Conference on Toxicology, February 25 - 26, 2016; United Kingdom; Faraday Discussion: Nanoparticles with Morphological and Functional Anisotropy, 46 July 2016, United Kingdom, International Association of Nanotechnology, California, USA, French Society for Nanomedicine, Lille, France.

Track 17:Nanomedicine Technologies

Nanomedicine technologiescould find an enhanced position in various areas and applications of the healthcare sector including drug delivery, drug discovery, screening and development, diagnostics and medical devices.BIOMEMSrefers to the application of micro electromechanical systems to micro- and nanosystems for genomics, proteomics, drug-delivery analysis, molecular assembly, tissue engineering, biosensor development, nanoscale imaging, etc.Nanoroboticsrefers to the still largely theoretical nanotechnology engineering discipline of designing and building nanorobots. Different companies are developing novel technologies in Nanomedicine likeNanoTherm therapyandNanobody technology. Nanomedicine in drug discovery is playing a key role in the growing part of pharmaceutical research and development.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Pharmacology andEthnopharmacology Conference May 02-04 2016, USA; Conference on Toxicogenomics June 09-10 2016, USA; Environmental ToxicologySummit August 25-26 2016, Brazil; BiosimilarsCongress September 12-14, 2016 USA; ToxicologySummit October 27-29 2016, Italy;Biosimilarsand Biologics Congress 1-2 February, 2016, Germany; The Oxford ChemicalImmunologyConference, 45 April 2016, United Kingdom; Toxicology and risk assessment conference, April 4-6, 2016; USA; 18th International Conference onBioinformaticsand Bioengineering, April 25-16, 2016, France; Toxicology Meeting, September 47, 2016, Turkey, Society for Personalized Nanomedicine, Florida, USA, European Society for Nanomedicine, Basel, Switzerland.

Conference Series LLCinvites the contributors across the globe to participate in the premier International Conference on Nanomedicine and Nanotechnology in Health Care (Nanomedicine-2016), to discuss the theme: "Nanomedicine: The Remarkable Technology Thats Changing the Face of Healthcare The conference will be held at Avani Atrium, Bangkok, Thailand during July 25-27,2016.

Conference Series Llc organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members

International Conference on Nanomedicine and Nanotechnology in Health Care (Nanomedicine 2016) aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Nanomedicine in Healthcare. It also provides the premier interdisciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Nanomedicine. The conference program will cover a wide variety of topics relevant to the nanomedicine, including: nanomedicine in drug discover and delivery, nanodiagnostics, theranostics, applications of nanomedine in healthcare applications and disease treatments.

Why to attend?

With members from around the world focused on learning about nanomedicine and its advances; this is your best opportunity to reach the largest assemblage of participants from the Nanotechnology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event.

Target Audience:

Nanomedicine Academia Professors , Medical professionals, Nanomedicine Department heads, Nanomedicine researchers, Nanomedicine CTOs, Nanomedicine product managers, business development managers, Entrepreneurs, Industry analysts, Investors, Students, Media representatives and decision makers from all corners of Nanoscience research area around the globe.

We therefore encourage all colleagues from all over the world to participate and help us to make this an unforgettable important and enjoyable meeting.

We look forward to seeing you in Bangkok, Thailand !!!

For more

10th International conference on Nanomedince and Nantotechnology in Healthcare

July 25-27, 2016 Bangkok, Thailand

Summary of Nanomedicine Conference:

Nanomedicine 2016 welcomes attendees, presenters, and exhibitors from all over the world to Bangkok, Thailand. We are delighted to invite you all to attend and register for the 10th International conference and exhibition on Nanomedicine and Nanotechnology in Healthcare which is going to be held during July 25-27, 2016 at Bangkok, Thailand. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Nanomedicine-2016, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Nanomedicine 2016 organizing committee look forward to meet in person.

Scope and Importance:

The emergence of nanomedicine and the application of nanomaterials in the healthcare industry will bring about groundbreaking improvements to the current therapeutic and diagnostic scenario. Some of the drivers of this market include increasing research funding, rising government support, improved regulatory framework, technological know-how and rising prevalence of chronic diseases such as diabetes, cancers, obesity, kidney disorders, orthopedic diseases and others.

Market Analysis:

In the past few years, the global nanomedicine market has witnessed an increasing use of novel nanomaterials and emergence of nanorobotics on a global front. The market has also observed a significant demand for personalized medicines due to its ability to treat patients based on customized treatments and other medical and genetic conditions.

Overall research in various disciplines:

The North American nanomedicine market held the majority of global market share in 2012 because of the rapidly growing nanomedicine market in the Asia-Pacific, Latin American and African region, presence of large number of patented nanomedicine products and favorable regulatory framework in the region. In addition, the presence of sophisticated healthcare infrastructure supports development of advanced products such as nano probes, nanorobots, monoclonal antibody based immunoassays and nanoparticle based imaging agents for early detection of diseases.

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as China, India and other economies in the region. China is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.

Nanomedicine study in various countries:

Companies involved in Nanomedicine:

GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories are some of the major companies in the Nanomedicine market.

Why Bangkok, Thailand?

Bangkok is the cultural, economic and political capital of Thailand. The city features both old-world charm and modern convenience. Many visitors in Bangkok are overwhelmed by the sheer size of the city and the vast number of attractions it has to offer. Indeed, there are many sightseeing opportunities in Bangkok, spanning for more than two centuries of rapid development following the citys founding in 1782. As Bangkok is considered a transport hub and a popular travel destination in Asia, we believe it would be beneficial to all the delegates who are attending the conference.

At present the research on nanomedicine is currently less due to the unavailability of funds and lack of proper expertise. The Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as China, India and other economies in the region. China is expected to surpass the United States.

Conference Highlights:

View original post here:
Nanomedicine Conferences| Nanotechnology conferences| 2016 ...

Menu Appointment Contact Us Visit Us Patient Portal

the pain ends here

Call (210) 293-3136

Start Your Treatment

Adult Stem Cell Overview

Platelet Rich Plasma

Stem Cells in the News

Read more

Read more

Regenerative Medicine

Frequently Asked Questions

The body of man [is] Gods drug-store and [has] in it all liquids, drugs, lubricating oils, opiates, acids, and anti-acids, and every sort of drug that the wisdom of God thought necessary for human happiness and health.

A. T. Still, Founder of Osteopathic Medicine

See what everyone is saying about STEM CELL Therapy in the news!!!

Stem Cells in the news

Comparing Joint Pain Solutions Thanks to modern medicine, we are living longer than ever! Everyone wants to live a long, happy life but longevity does have some downsides. Arthritis impacts nearly

Read more

Regenerative medicine is an increasingly important, incredibly promising area of medicine which focuses on improving the repair and regeneration of damaged tissue. Organ and bone marrow transplants were early forms

Read more

DECEMBER 2015 SAN ANTONIO SCENE The Stem Cell Orthopedic Institute of Texas offers stem cell and platelet rich plasma (PRP) procedures as viable alternatives for individuals suffering from joint pain, joint

Read more

THE STEM CELL ORTHOPEDIC INSTITUTEOF TEXASat the medical center in San Antonio offersSTEM CELLandPLATELET RICH PLASMA (PRP) Therapies to help individuals suffering from joint pain, joint and tendon degeneration, and

Read more

You may be a candidate for STEM CELL Therapy. Call (210) 293-3136 today to schedule your medicalevaluation. Courteous Patient Advocatesare standing by to answer your questions.

Start Your Treatment

The STEM CELL ORTHOPEDIC INSTITUTE of Texas 5282 Medical Drive Suite 200 San Antonio, TX 78229

Phone: Call (210) 293-3136

See the article here:
Stem Cell Therapy, Surgery, Transplant & Treatment | Stem Cell

Healthy aging and longevity in humans are modulated by a lucky combination of genetic and non-genetic factors. Family studies demonstrated that about 25% of the variation in human longevity is due to genetic factors. The search for genetic and molecular basis of aging has led to the identification of genes correlated with the maintenance of the cell and of its basic metabolism as the main genetic factors affecting the individual variation of the aging phenotype. In addition, studies on calorie restriction and on the variability of genes associated with nutrient-sensing signaling, have shown that ipocaloric diet and/or a genetically efficient metabolism of nutrients, can modulate lifespan by promoting an efficient maintenance of the cell and of the organism. Recently, epigenetic studies have shown that epigenetic modifications, modulated by both genetic background and lifestyle, are very sensitive to the aging process and can either be a biomarker of the quality of aging or influence the rate and the quality of aging.

On the whole, current studies are showing that interventions modulating the interaction between genetic background and environment is essential to determine the individual chance to attain longevity.

The research on aging, and in particular the search for the determinants of successful aging and longevity, has been continuously growing in the last decades also due to the social and medical burden correlated to the continuous increase of lifespan in western countries and the consequent grow of the elderly population. One of the main questions in this field is the correlation between the genetic background and lifestyle in determining the individual chance of a delayed aging (possibly without age-related diseases and disabilities) and longevity. The results obtained by biogerontologists in these years, which highlighted most of the biological and biochemical mechanisms involved in the aging process, allowed to better understand such correlation. This has brought to elaborate important strategies focused on possible interventions to improve lifestyle in order to increase the chance to attain longevity by modulating the basic molecular mechanisms of aging.

Before the 1990ies it was largely spread the idea that aging is ineluctable and that genetics does not control it. It was important, in this view, the idea that aging occurs after reproduction, and then there is no need, but also no opportunity, for selection to act on genes that are expressed during this late period of life [1].

The researcher who pioneered the genetics of aging and longevity was Tom Johnson, who studied groups of C. elegans where he was able to separate long living individuals from short living subjects. The analysis of hybrids obtained from different strains of C. elegans, allowed to estimate that the heritability of life-span was between 20 and 50% [2, 3]. Subsequently, he started the analysis of different mutants and, with M. Klass, found a number of mutants with longer lifespan. Subsequently, Tom Johnson found out that most of the mutants with long lifespan had mutations in the age1 gene [4]. This gene turned out to be the catalytic subunit of class-I phosphatidylinositol 3-kinase (PI3K).

The studies of Johnson clearly demonstrated that genetic variability could indeed affect lifespan. This triggered many studies in model organisms in order to disentangle the different biochemical pathways which could affect lifespan, and to highlight the genes coding for the proteins involved in such pathways. In particular, yeast, C. elegans, drosophila and mice were analyzed and this highlighted numerous genes which could affect lifespan if mutated (for an updated list of these genes see http://genomics.senescence.info/genes/models.html). Most of these genes are related to the maintenance of the integrity of the cell (especially the integrity of DNA). In C. elegans, however, some of the main genes which have been found to modulate lifespan (daf2, daf16) are related to the ability to enter the dauer status [5, 6], that is a quiescent status (usually entered in case of nutrient deprivation) with a minimum energy expense, which causes an arrest of the reproduction process and allows the organism to live longer expecting for the availability of nutrients. This suggested that longevity can be attained by means of an efficient maintenance of the cell but also by diverting resources from reproduction to self maintenance, in line with previous findings that dietary restriction can extend lifespan. After the characterization of these genes in C. elegans, it was found that in mice the ortholog of daf16 (FOXO) could affect lifespan. In mammals, FOXO is correlated to the Insulin/IGF1 axis which is stimulated by nutrient availability and, through FOXO, promotes protein synthesis [711].

It is of note that some Authors suggested these molecular mechanisms modulating lifespan could be due to a pleiotropic effect of genes which have evolved for different purposes (such as the genes in the IGF-1 pathway which have evolved to face presence/absence of nutrients) but can, ultimately affect lifespan; others proposed that some genes may have evolved to program aging and avoid immortality, as this would hamper the continuous substitution of old subjects with new, younger, ones [12, 13].

It was obviously inevitable that the research of the genetic basis of longevity turned to human beings and investigated whether the common genetic variability of human populations could affect inter individual differences in lifespan but also whether the genes found to prolong lifespan in model organisms, on turn, were correlated to human lifespan.

As to the first question (does common genetic variability affect lifespan, and in particular does it affect longevity?), this has been studied by two approaches. The first one was the reconstruction of the sibships of long-lived subjects [14, 15] and the comparison of their survival curves with those of the birth cohorts born in the same geographical area. This approach demonstrated that brothers and sisters of the long-lived subjects had a clear survival advantage (at any age) with respect to the general population. The second approach, with intrafamily controls, was started in order to distinguish the genetic from the familiar effect. Montesanto et al. [15] compared the survival function of brothers of centenarians with those estimated for their brothers in law, that is with the men who married their sisters; these men were supposed to share with the brothers of the long lived subjects the familiar environment. By using this second approach, it has been found that the survival advantage of siblings of long-lived subjects was not completely shared by their brothers in law, despite they shared the same environment for most of their life. This suggested that beyond the family environment, there are genetic factors influencing survival and, consequently, lifespan. Interestingly, in this study, the survival curve of the sisters of long-lived subjects did not differ from the one of sisters in law, suggesting that the genetic component does explain lifespan in men more than in women. The genetic component of lifespan in humans has also been analyzed by comparing the age of death of monozygotic and dizygotic twins. This has allowed to estimate that about 25% of the variation in human longevity can be due to genetic factors and indicated that this component is higher at older ages and is more important in males than in females [1618].

In parallel to these studies, many researches have been carried out to search the genetic variants responsible of modulating human longevity. Most of them were carried out by a case/control approach, by comparing the frequency of specific polymorphisms in long-lived subjects and in younger geographically matched controls. The rationale of this study design is that as the population ages, alleles favorable for survival will be present at higher frequency among long-living people, while unfavorable alleles will be eliminated [1921]. The candidate genes analyzed by this approach were either genes involved in age-related diseases (such as APOE, which had been observed to be involved in the predisposition to Alzheimer Disease and other age-related cognitive impairments), or genes implicated in pathways related to longevity in studies with model organisms (IGF-1, FOXO, Sirtuins) [2225]. This study design has indeed led to find numerous polymorphic genes the variability of which affects longevity. However, each of these polymorphisms turned out to explain only a very small fraction of the longevity variability. Indeed high-throughput Genome-wide analyses, which have recently been carried out have identified many genes positively associated with longevity but only a very few ones could hold multiple test significance and successfully replicated in different studies and across different populations [2629]. Population stratification and inadequate sample sizes are among the main plausible explanations [30]. The adoption of innovative study design and the development of new statistical and computational tools for effective processing of genetic data arising from high-throughput DNA technologies will help to better understand the complex genetic architecture underlying human longevity [31, 32].

A new way of looking at the genetic data has been proposed by Raule et al. [33] who analyzed the complete sequences of mitochondrial DNA from long-lived subjects coming from different areas of Europe. The availability of complete sequences allowed to evaluate for the first time the cumulative effects of specific, concomitant mitochondrial DNA (mtDNA) mutations, including those that per se have a low, or very low, impact. The analysis indicated that the presence of single mutations on mtDNA complex I may be beneficial for longevity, while the co-occurrence of mutations on both complexes I and III or on both I and V might lower the individuals chances for longevity. Previous analyses on single mutations falling on complex I (either specific mutations or mutations defining groups of haplotypes) had given contrasting results, showing association with longevity in some cases but not in others. It is likely that positive results were obtained in populations were mutations on complex I were not associated with mutations on complex III or V, while negative results were obtained in populations with high prevalence of mtDNA haplotypes carrying mutations on complex I in association with mutations in complex III and V. This approach confirmed that most of the genetic variants have a very limited effect on longevity, and that only their cumulative effect can give a consistent appreciable effect and suggests that a limit of previous analyses has been to search for single mutations instead of cumulative effects. On the other hand, it is very difficult to think of using such approach, which has been successful for mitochondrial DNA, on genomic DNA unless small fractions (or specific regions harboring genes involved in relevant pathways) are analyzed.

On the whole, the genetic association studies suggested that, also in humans, mutations in genes correlated with the maintenance of the cell and of its basic metabolism are essential in modulating lifespan. Indeed, genes involved in DNA repair [34], telomere conservation [3537], heat shock response [38, 39], and the management of free radicals levels [33, 40] were found to contribute to longevity or, in case of reduced functionality, to accelerated senescence (cellular aging) and the consequent organism aging. In addition, as suggested by the studies in mice, the pathways involved in nutrient-sensing signaling and in regulating transcription, such as IGF-1/insulin axis [41] and TOR (target of rapamycin) [42] showed to be involved in modulating human longevity. Besides these genes involved in cellular maintenance/metabolism and senescence, concurrent efforts, especially from clinical studies, also showed that genes implicated in important organismal process may have a strong impact on aging and longevity. For instance genes involved in lipoprotein metabolism (especially APOE), cardiovascular homeostasis, immunity, and inflammation have been found to play an important role in aging, age-related disorders, and organism longevity [4346].

Life expectancy at birth has been increasing for most of the last century in western societies, thanks to the continuous amelioration of medical assistance, to the improvement of the environment (in particular clean, safe water and food), and to the improvement of nutrients. For instance, in Italy life expectancy went from 29years in 1861 to 82 in 2011 (Table

reports the evolution of this data in women and men). Similarly, the extreme longevity has been growing in these years. Indeed, the number of centenarians (still in Italy) remarkably increased from 165 in 1951 to more than 15000 in 2011. These results have been attained first by a dramatic reduction of infectious diseases, which, on turn, has dramatically reduced infantile mortality, but also mortality in adult age. In fact, in 2011 less than 10% of deaths occurred in subjects under 60years of age, while the corresponding figures were 74% in 1872, 56% in 1901 and 25% in 1951. However, in the last decades, the continuous extension of lifespan was mainly due to the improvement of medical assistance with respect to age-related diseases, especially Cardiovascular Diseases and Cancer, which allowed to increase lifespan of 5years in the last 2 decades and of 2years in the last 10years (data from

and

).

Evolution of lifespan expectancy in Italy from 1861

1861

28

29

29

1871

30

31

30

1881

35

35

35

1891

38

39

38

1901

43

43

43

1911

46

46

46

1921

48

50

49

1931

53

56

55

1941

55

58

56

1951

63

67

65

1961

67

72

69

1971

69

75

72

1981

71

78

75

1991

74

80

77

2001

77

83

80

2011

79

84

82

These data clearly show that environmental factors have a very strong impact on lifespan and on longevity in humans. However, the extension of lifespan that there has been in the last decades have not been accompanied by a similar extension of healthy lifespan. Indeed, in most cases this lifespan extension is due to the chronicit of the age-related diseases. This has brought the community of biogerontologists to study interventions, possibly modulated on the knowledge emerged from the studies on the genetic and biomolecular basis of longevity, to extend not only lifespan but also healthy lifespan, or, with a new word, healthspan. In fact, model organisms with mutations that extend lifespan have a healthy life also when they are old. This suggested that health span extension could be attained by targeting (stimulating or silencing) the genes, which had been highlighted to be involved in life extension in both model organisms and humans [47]. In support of this hypothesis, it has been reported that dietary restricted mice, which live much longer and show a very delayed aging phenotype than mice fed at libitum, at old age have an expression pattern very different from mice of the same age for a number of genes correlated with life extension, such as those related to DNA repair, stress response, immune response and others [48, 49]. Thus, dietary restriction can trigger a molecular-genetic response which postpones aging and age-related phenotypes. This has brought to search for drugs or interventions which may act on these mechanisms without the side effects of calorie restriction. Among the most important interventions which have been considered in this context, we may name the protein restriction, the use of drugs targeting different genes of IGF-1 axis or of the FOXO/TOR pathway [47]. In addition, these studies have allowed to reconsider previous data on some areas characterized by exceptional longevity (such as Okinawa, Sardinia and Calabria) which are characterized by traditional ipoproteic diets, such as the Mediterranean diet [5053]. In these cases, then, the environment, that is the traditional diet, has allowed to stimulate the molecular mechanisms which can increase life span.

Among the several changes that occur with the aging process, in the last decade Epigenomics has attracted the interest of many researchers. This was mainly due to the fact that epigenetic modifications summarizing, at least in part, the interaction between the individual genetic background and lifestyle characteristics, should be potentially able to capture part of the unexplained susceptibility observed today for complex diseases (the so-called missing heritability problem).

Starting from the pioneeristic observations that epigenetic modifications affect not only the aging process but also its quality (successful aging) [54], EpiGenome-Wide Association Studies identified hundreds of sites spread along the entire genome in which methylation levels change between oldest old and younger subjects. In particular, Horwat and co-workers, on the basis of the methylation levels of 353 CpG units, formulated a mathematical model, the so-called epigenetic clock, that showed some important properties [55]. First, it was able predict the chronological age of a subject starting from the methylation level of several cells and tissues of his body. Second, it represents one of the most accurate biomarker of age (also superior to the estimates obtained from the telomere length). Third, using methylation levels of blood and brain tissues from subjects affected by Down syndrome, it showed that an accelerated aging occur in such a syndrome [56]. Fourth, it was able to predict all-cause mortality also after adjusting for traditional risk factors [57]. Finally, when it was used to estimate the biological age of several tissues from supercentenarians, it has been demonstrated that brain and muscle represent the youngest tissues of these exceptional individuals [58].

However, even if the cause-effect relationship between methylation process and aging is still not clear, the potential applications of this discovery are very wide, ranging from detailed monitoring of changes occurring with age within individual systems or organs (muscle, brain, etc.) to forensic purposes. For this and several other reasons, future advances in this field could help the understanding of the complex physiology of aging, lifespan and age-associated diseases.

See the article here:
Human longevity: Genetics or Lifestyle? It takes two to ...

All treatments performed at Lung Institute utlize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

The treatments, claims and other information contained on this page and LungInstitute.com have not been evaluated or approved by the FDA. Any individual that accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

View post:
Lung Institute | Stem Cell Therapy For Lung Disease

Stem cell research carries a broad variety of impacts on society and law. Being a branch of the relatively new field of regenerative medicine, stem cell research has evolved over the years as human knowledge of cellular biology has expanded. The history of translational stem cell research is yet even smaller. This small history leads to a great uncertainty over stem cell research work.

Some of the societal issues of stem cell research are:

Implications of stem cell knowledge - As society continues to develop its knowledge of stem cell biology, will all knowledge be ultimately translated to only cures? Can too much knowledge of our own bodies lead to harm due to conditions like paranoia or anxiety? Will medical professionals become biased against other forms of treatments if stem cells do indeed prove to treat or cure a variety of diseases?

Implications of the power to cure or treat disease - If many stem cell treatments are developed, who will control the distribution of treatments? Will medical professionals be free of bias due to race, ethnicity, gender, or age, when providing stem cell treatments? Is the general public responsible enough to view stem cell therapiesin a mature way? What will happen if the general public begins to perceive stem cells as "miracle cures"? Can we control the extent to which people believe in the effectiveness of stem cell therapies?

In simple words, the sociological impact of stem cell research is outstanding when considered in the context of humans and human history. Disease and illness have devastated human populations since human beings first originated. If stem cell treatments are discovered, do they indeed become the last avenue of innovation in biomedical research and science? Is stem cell research truly as far as we can go for cures?

The legal impact of stem cell research is also very significant.

More:
Societal and Legal Issues of Stem Cell Research - Yola

Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered cartilage or bone, and the treatment of cardiovascular disease.

An interdisciplinary team of Queen's University researchers led by Dr. Lauren Flynn, a professor in the Departments of Chemical Engineering and Anatomy and Cell Biology, has been working with stem cells extracted from samples of human fat and is developing new methods in the lab to develop these cells into mature tissue substitutes.

While stem cells extracted from fat cannot be grown into as many different types of cells as embryonic stem cells, they do have a number of advantages.

"The advantages include less ethical controversy, abundant cell availability from discarded tissues from elective surgeries like breast reductions and tummy tucks, and a much reduced possibility for immune rejection when re-implanting cells extracted from a person's own fat," explains Dr. Juares Bianco, a postdoctoral fellow in the Department of Chemical Engineering and the Human Mobility Research Centre (HMRC) who is working in the Flynn lab group.

Sarah Fleming, a Master's candidate in the group, is also working to establish a new method for growing the fat stem cells in the lab using a system that mimics the natural tissue environment found within the body. This work is based on Dr. Flynn's development of a technique for washing away all traces of cells from a sample of body fat, leaving behind a three-dimensional tissue scaffold that she calls "decellularized adipose tissue," or "DAT" for short.

This empty scaffold can then be used for soft tissue reconstruction or as a growing environment for the extracted stem cells. Dr. Flynn's preliminary studies have shown that when the stem cells are grown on the DAT scaffold, they naturally begin to mature into fat cells, suggesting that the engineered growth environment influences the type of cell that the basic stem cells will turn into during the tissue regeneration process.

This research was funded in part by NSERC's Collaborative Research and Training Experience Program (CREATE) and was conducted by researchers in the Human Mobility Research Centre (HMRC). The HMRC is a partnership between Queen's University and Kingston General Hospital and serves as a point of collaboration between the disciplines of medicine, engineering, health sciences, and information technology.

Story Source:

The above post is reprinted from materials provided by Queen's University. Note: Materials may be edited for content and length.

See the rest here:
Extracting stem cells from fat for tissue regeneration ...

Whether you are newly diagnosed with breast cancer in New York, Chicago, or Los Angeles, new advances in technology are available that can determine the biology of your specific tumor type by using genetic testing for breast cancer. This information is used to tailor your cancer treatment plan around your specific tumor biology to give you the best outcome and possibly avoid the side effects of breast cancer treatment. Why have chemotherapy if your tumor wont respond to it? Why have hormonal therapy if you wont receive any benefit?

Targeting Therapy for YOUR cancer

Matching an individuals biology with a selected therapy is called personalized medicine, and attempts to use targeted therapy for breast cancer. Looking at the genes in your tumor and determining how the genes are functioning is the first step in personalizing your medical plan. Once the genomic test has been performed, the breast cancer recurrence test, along with your personal clinical and pathological factors, will tell you and your doctor how your tumor is behaving and to which therapy it will best respond.

Juliann Reiland, MD, Breast Surgeon, Avera Medical Group, Sioux Falls, SD

John Link, MD, Breast Oncology, Breastlink, Orange, CA

The main reason we can individualize your medical treatment is that we can now look at specific genes in your tumor that show how your tumor is behaving: whether it is a more aggressive tumor and requires chemotherapy or whether it is a less aggressive tumor and other milder therapies might work just as effectively but without the caustic side effects of chemotherapy.

Looking at tumor cells gene expression is called genomic profiling, or genomic testing.

Genomic testing measures how your tumor genes are being expressed which tells physicians how your tumor will behave. Once you know what type of tumor you have and how it behaves, you and your doctor can tailor the right approach, or personalize your treatment plan.

No two tumors are the same.Their treatments shouldnt be either.

Personalized medicine is about tailoring your treatment plan for your tumor. In order to do this, you need to know the genomic makeup of your tumor.

How do you do that?

Get a genomic test on your tumor. Find a doctor.

Peter D. Beitsch, MD FACS, Breast Surgical Oncologist, Dallas Surgical Group, Dallas, TX

Below is an edited transcript of a Twitter chat held Oct. 21, 2015 and sponsored by the Tigerlily Foundation (Twitter: @tigerlilycares). The chat was organized under #ybcsempowered Young Breast Cancer Survivors Empowered. The discussion focused on molecular diagnostic (genomic) testing for breast cancer.

TigerLily Twitter Chat Transcript

See the original post here:
Personalized Medicine | Breast Cancer New York & LA

If you've suffered a sports injury -- whether you're an elite athlete or just having fun in the backyard -- St. Francis Sports Medicine has what it takes to get you back in action. Our highly-trained network of physicians, athletic trainers and physical therapists work as a team to treat all types of sports-related injuries; even injuries that don't occur from playing a sport.

We treat athletes of all levels: elite professionals and college-level athletes, recreational athletes and young people in team sports. No matter where you fall in the spectrum, we take your unique situation into account and develop a care plan to help you reach the goals you set for yourself.

The St. Francis Sports Medicine team is specially-trained in taking care of sports medicine patients. Our physicians are fellowship-trained, our athletic trainers are nationally certified, and our therapists are among the most experienced in the Upstate. These professionals work as a team, communicating your expectations and goals to develop a comprehensive care plan that is unique to your situation. This team approach means that each component of your recovery is managed by a professional who specializes in that area. Meet the Elite >>

At St. Francis, your surgeon has access to state-of-the-art facilities and the latest technology which can mean easier surgeries, less scarring and a faster recovery. And because youre at St. Francis, you receive the highest quality of care from our staff. We provide a range of technologies to help your physician properly diagnose your condition, including advanced imaging equipment that produces incredibly detailed scans in a very short time. We also offer state-of-the-art surgical facilities designed and equipped to accommodate complex, multi-dimensional procedures as well as the most commonly performed surgeries. Throughout the entire surgical experience, our caring, highly-trained staff supports surgeons during surgery, families who are waiting, and patients both before and after their operations.

The 675-HURT hotline is St. Francis Sports Medicines 24/7 concierge service for sports injury care. When you experience a sports injury, calling 675-HURT gets you in touch with a medical professional who can offer instructions for at-home treatment and advice for next steps. If needed, you'll also receive priority appointment times with our elite network physicians, or call-ahead service at St. Francis Emergency Departments, significantly reducing wait times. The professionals at 675-HURT even assist in scheduling post-visit appointments, like physical therapy or rehabilitation, as prescribed by your doctor.

St. Francis Sports Medicine is proud to provide team physicians and athletic trainer services to:

The Sports Performance Enhancement program is designed to help athletes of all levels reach their maximum potential. With two distinct programs, our experts create individual training regimens to either boost performance or help you recover from an injury or surgery.

Our support doesnt end after youre discharged from the hospital. To get you back in action, our Outpatient Rehabilitation program offers physical therapy that helps re-train your body and return you to full function. We offer a core strengthening program and can help identify areas of muscle imbalance both of which reduce the chance of future injuries. Learn more >>

Read more from the original source:
Sports Medicine Greenville, SC - St. Francis Health

Our Sports Medicine Joint Repair franchise offers surgeons a broad array of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder:

Our franchise operates in a large, growing market where unmet clinical needs lend room for procedural and technological innovation. Smith & Nephew is well positioned both to innovate and to reach customers globally.

Recently, our position within the global Sports Medicine joint repair market was strengthened significantly with the acquisition of ArthroCare Corporation. The transaction added technology and highly complementary products to our existing portfolio, including new shoulder anchor innovation.

Key products in this franchise include the FAST-FIX family of meniscal repair systems, the ENDOBUTTON family for knee ligament reconstruction, HEALICOIL PK, FOOTPRINT PK and TWINFIX Suture anchors for repairs of the hip and rotator cuff.

In 2015, Smith & Nephew launched its Q-FIX All-suture anchor for procedures like rotator cuff repair in the shoulder and labral repair in the shoulder and hip, all procedures in which anatomic space is very limited. The new anchor delivers performance characteristics that meet or exceed those of much larger, hard anchors.

Key products in resection are the wide range of DYONICS shaver blades, ACUFEX handheld instruments, and a range of radiofrequency (RF) probes. The DYONICS PLATINUM Series Shaver Blades, launched in 2011, are single-use blades that provide superior resection, debris evacuation and sharpness.

Other recent innovations include the BIORAPTORand OSTEORAPTOR CURVED Guide Systems for Shoulderthat optimise anchor placement, helping surgeons to overcome the challenges associated with instability repair. The systems provide increased access to the repair site in the glenohumeral joint, improve the trajectory of drilling and lead to optimised anchor placement in glenoid bone which helps surgeons operate with confidence.

Click here to see our key sports medicine products.

Read more from the original source:
Sports medicine, minimally invasive joint surgery | Smith ...

UI Sports Medicine offers convenient access to the very best sports medicine option for athletes of all ages, from casual exercisers to intense college and professional athletes.

For 30 years, UI Sports Medicine has taken care of the University of Iowa Hawkeyes. That same staff offers a full spectrum of care, including the treatment and rehabilitation of serious injuries.

Our multidisciplinary approach brings together physicians and staff from family medicine, pediatrics, orthopedics and rehabilitation therapies who specialize in the evaluation and diagnosis of musculoskeletal problems.

UI Sports Medicine is ready to help you if:

The UI Sports Medicine facility houses all the toolssuch as X-ray, ultrasound, and MRIneeded to diagnose and treat a range of injuries from ankles to shoulders to concussions. All patients have access to comprehensive rehabilitation services, including:

Among the clinical services offered by UI Sports Medicine are:

The UI Sports Medicine Center, part of the Institute for Orthopedics, Sports Medicine and Rehabilitation, is home to state-of-the-art clinical and rehabilitation facilities. The 26,000-square-foot building includes 16 examination rooms and four treatment rooms.

Almost 7,500 square feet is devoted to comprehensive rehabilitation services, including a hydrotherapy pool, custom orthotics, athletic shoe wear modification and bracing, training aids and rehabilitation accessories.

In addition, the facility houses other medical specialties, including children's injuries and orthopedic clinics devoted to treating disorders of the hand, shoulder, foot and ankle.

The proximity of surgical and medical clinics with rehabilitation facilities and comprehensive orthopedic and prosthetic services underscores the center's multidisciplinary approach to sports medicine and allows patients to have all their needs met under one roof.

UI Sports Medicine clinicians and researchers provide in-depth patient education materials on everything from preventing sports injuries to nutrition recommendations for athletes.

Read more:
Sports Medicine - University of Iowa Hospitals and Clinics

100% Confidential. No Obligation.

At HealthGAINS we like to consider ourselves an alternative to Cenegenics for your Hormone Therapy. There are a number of reasons why we feel HealthGAINS is the right choice, but listen firsthand to HealthGains member, on why he chose us over Cenegenics.

You are a unique individual with specific needs. Our programs are carefully customized to fit your lifestyle. Our priority is to improve your quality of life so you can accomplish more.

Dont Waste Your Time

When starting out with Cenegenics , expect to spend 8-9 hours getting overwhelmed with information and unnecessary test recommendations that dont make sense to the average person. We can think of much better ways to spend those hours.

At HealthGAINS we understand that your time is valuable were all busy. Our staff will help you schedule all the essential tests without trying to upsell you unnecessary exams to inflate the bill and waste your time. Cenegenics Alternative in Florida >>

Although we pride ourselves on efficiency, you will never feel rushed or hurried when youre in the office. Our doctors and support specialists are more than happy to hear you out and address your concerns. You can rest assured knowing that youre in good hands with our medical professionals. They will quickly follow up with you regarding any test results and routinely check up on your progress. Now thats great customer service!

Take the First Step

Let us help develop a personalized hormone therapy for you. Call us today at 1-800-325-1325 for a FREE consultation or complete the contact form. Were ready to guide you every step of the way.

--------------------------------------------------------------------------------

**Cenegenics is a registered trademark of Cenegenics, LLC. AAGHealthGainsis not affiliated in any way with Cenegenics products or services.

More:
Cenegenics Alternative - AAG Health & Wellness

Sermorelin Acetate Therapy with GHRP-6

With Sermorelin Acetate Therapy, it is possible to restore youthful vitality and alleviate the effects of the aging process that result from Human Growth Hormone Deficiency. Sermorelin is a safe and effective hormone substitute which has the capability to naturally stimulate the Human Pituitary Gland in order to encourage the secretion of our own internal stores of Human Growth Hormone.

HGH is created by endocrine organs known as Somatotrophs located in the Anterior Pituitary. Although as we grow older, the body drastically slows down production of HGH over time, the Somatotrophs never lose their ability to produce healthy levels of HGH. This is why Sermorelin Injections are an effective treatment for Growth Hormone Deficiency.

What is Sermorelin?

Sermorelin is the bio-synthetic form of a hormone naturally produced by the hypothalamus, known as Growth Hormone-Releasing Hormone. GH-RH is the means by which the brain sends a request to the pituitary to release HGH. GH-RH is delivered from the Hypothalamus to the Pituitary Gland via a pathway of blood vessels known as the Hypophyseal Portal System.

How is Sermorelin different from Bio-Identical HGH?

Unlike Bio-Identical Human Growth Hormone Replacement Therapy, Sermorelin Acetate is not structurally identical to GH-RH, but Sermorelin Acetate is functionally capable of producing the same biological effect on the body that is achieved naturally through GH-RH. Sermorelin Acetate is a truncated form of GH-RH, which means that the bio-synthetic hormone is structurally identical to the active portions of the GH-RH molecule, while omitting portions of the molecule that are inert and do not encourage the release of HGH. Although the Sermorelin molecule is not naturally produced by the body, there are no adverse effects related to the exogenous nature of the hormone. The treatment is perfectly safe.

HGH Decline Begins around Thirty

Adult Human Growth Hormone production reaches its peak by the time we reach the age of around twenty. Over the course of our twenties, we maintain high levels of HGH production which help us sustain ourselves physically, cognitively, and psychologically. By the time we reach the age of thirty, however, Growth Hormone Production starts to decline at a slow, yet insipid rate of one to two percent each year. Although this may not sound like a significant amount at first, this amounts to an average reduction in endogenous HGH production of around 14% every ten years! By the time a decade of decline has occurred, the human body only produces 40% of the Human Growth Hormone emitted during the period of peak production in our early twenties.

Symptoms of HGH Deficiency

This decline in HGH secretion does not come without significant health consequences. HGH Deficiency is correlated with a number of symptoms and and syndromes that we take for granted as simply a part of the aging process, such as:

Immune Suppression

Decreased Cognitive Sharpness

Wrinkles and Deep Lines

Increased Adipose Fat, Especially around the Midsection

Reduced Libido

Fatigue

Reduced Willpower and Motivation

Many Other Symptoms throughout the Body

Benefit of Sermorelin Vs. Other Treatments

Although HGH Hormone Replacement Therapy is a safe and effective means of restoring healthy Human Growth Hormone Levels, Sermorelin Acetate Injections completely eliminate the risk of overdose while encouraging the Pituitary Gland to be responsible for the dispensation of HGH rather than self-administration techniques. Sermorelin Acetate presents no risk of HGH Overdose because HGH production by the pituitary is down-regulated by effective biological negative feedback mechanisms.

Sermorelin and Somatostatins

When the brain feels that the human body has a sufficient amount of Human Growth Hormone necessary to maintain optimal health and hormone balance, the hypothalamus releases the inhibitory hormone Somatostatin, which blocks the uptake of Sermorelin and GH-RH by the Hypothalamus, preventing the brain from overloading the body with excess HGH. Because of the effectiveness of Somatostatin at effectively regulating the pituitary, the risk of Growth Hormone Overdose Via Sermorelin Injection is nearly impossible

Clinical Body Fat Reduction Using Sermorelin

Clinical trials show that after a single year of Sermorelin Acetate Therapy, it is possible to achieve a 20% reduction in adipose fat tissue. The majority of this fat tissue is eradicated from the midsection. Fat from the waist, hips, and stomach decline by around 30% while weight loss occurs via marginal areas of body fat such as the legs, arms, neck, and chest at a mass percentage of around 13%.

Sermorelin is Delivered Via Injection

Sermorelin Acetate is a low risk treatment which is delivered via small injections just below the top layers of the skin, known as subcutaneous injection. These shots are simple to administer and patients generally perform their own injections in the privacy of their own homes or offices.

Why is Sermorelin Combined with GHRP-6?

Many treatment protocols combine Sermorelin Acetate Therapy with GHRP-6. GHRP-6 is a synthetic hormone which functions similarly to Sermorelin by encouraging the healthy stimulation of the Pituitary Gland. Although the two hormones achieve the same end, they do so via different chemical pathways and enzyme reactions. GHRP-6 is useful because it helps emulate the normal biological cycle of HGH Release, providing more noticeable gains in HGH Levels than Sermorelin Acetate injections alone while still producing biologically safe levels of Human Growth Hormone.

GHRP-6 and Ghrelin

GHRP-6 shares no significant structural similarity to any hormone produced naturally by the human body, but synthetic GHRP-6 has been proven to encourage the production of Growth Hormone by simulating the biological effect of the hormone Ghrelin on pituitary stimulation. Ghrelin is primarily produced by the stomach and plays a significant role in gastrointestinal function, but the hormone also influences HGH production as well, which is not surprising considering that Human Growth Hormone stimulates cellular metabolism. Ghrelin is an acronym for Growth Hormone-Releasing Peptide.

The Effect of Age On GH-RH Production

GH-RH is released at its highest rates during our youth, which corresponds directly with the rate at which our pituitary releases HGH at its most abundant. As we grow older, GH-RH levels start to decline, leading directly to a deficiency of Human Growth Hormone which speeds up the aging process and reduces overall health and well being as a result. HGH Deficiency is also referred to as Hypopituitarism, relating to the suppression of pituitary function that causes the organ to release insufficient levels of vital Growth Hormone.

Phases of HGH Decline

At first, the effects of Hypopituitarism are qualitative in nature and relatively hard to measure, yet vivid to experience. Low HGH first affects energy levels, which can affect overall motivation and suppress innate desires. After energy levels start to decline, the body starts to experience greater levels of fatigue on a physical level. Aside from being sapped of mental energy, the human body loses its ability to sustain itself in the face of high levels of activity. Endurance starts to decrease significantly, and during this period, the body becomes less prepared for high levels of physical exertion and gains from exercise start to decline.

Also, the bodys capacity for restorative sleep starts to drop, exacerbating further decline. During the third phase of HGH Deficiency, overall health starts to deteriorate as well. Early in this phase, aesthetic skin health starts to decline rapidly as wrinkles and deep creases start to develop. Cholesterol and Triglyceride levels increase, hypertension often develops as a result of cardiovascular strain and arterial plaques. The body begins to seep calcium from deep within the bones, which inevitably leads to symptoms of osteoporosis over time. During this phase, the body not only responds less readily to exercise, but it will be difficult to make significant gains at all, and in the worst cases, exercise will only serve to prevent muscle atrophy from occurring.

Goal of Sermorelin Therapy

Sermorelin Therapy with GHRP-6 has the potential to alleviate or even reverse many of the symptoms of HGH Deficiency and aging listed above. The Conscious Evolution Institute is one of the premier Anti-Aging Clinics in the country, and we specialize in the legal and legitimate use of Hormone Replacement Therapy as a means to encourage a longer life with enhanced health outcomes. Our fully-trained and board-certified staff of clinical specialists and physicians are dedicated to helping our patients live a longer and healthier life that is full of vigor, energy, and characterized by an overwhelming sense of well-being.

Sermorelin and GHRP-6

Sermorelin Acetate Therapy with GHRP-6 is a verified safe, effective, and biologically self-containing means to stimulate the pituitary to produce healthy and normal levels of Human Growth Hormone by emulating the effects of GH-RH and Ghrelin on Somatotroph activity. Sermorelin GHRP-6 is available at numerous pharmacies across the United States and is generally compounded on site by a licensed pharmacist. Sermorelin Therapy is not subject to the same restrictions as Bio-Identical Human Growth Hormone, and is available with a physicians prescription.

Unlike HGH Hormone Replacement Therapy, there are no legal restrictions placed on the prescribing physician in regard to his or her medical expertise and opinion, and as a result, Sermorelin Injections can be prescribed off-label in order to treat many symptoms of HGH Deficiency that have been clinically shown to be beneficial, yet have not yet been approved by the FDA.

View original post here:
GHRP-6 Sermorelin Blend Injections - kchormone.com

Download Patient Registration Forms

View MultimediaPatient Education

See What Our Patients Are Saying

Patient Portal Link Billing & Accounting

Patient Portal Link Access Health Records

The Orthopedic & Sports Medicine Institute of Las Vegas provides a full spectrum of Orthopedic and Sports Medicine needs in Las Vegas and the greater region. Dr Bascharon is an innovator, who always strives for cutting-edge strategies and solutions to keep you well, with or without surgery. She provides meticulous care and assurance throughout the surgical or non-surgical treatment phases.

Our goal is to provide patients the same level of education and service in Orthopedics and Sports Medicine that we would desire for ourselves. Our intention is to offer you the latest and most sophisticated stage of technology in the field of Orthopedics and Sports Medicine.

It is a pleasure to welcome you into our practice. Our well versed staff is ready to assist you with any questions or concerns. Please feel free to contact our office at anytime.

See the rest here:
The Orthopedic & Sports Medicine Institute of Las Vegas ...

Pediatric Endocrinology

The Division of Pediatric Endocrinology and Diabetes at Children's Mercy Kansas City is one of the largest full-service programs in the country and recently ranked as one of the top 25 programs in the nation byU.S. News and World Report. Patients are monitored regularly and have access to a full range of care and support services to help them lead healthy lives today and into adulthood.

Pediatric Endocrinologists and Diabetes Specialists

Our team includes more than20 pediatric endocrinologists and nearly 100 employees specializing in endocrine disorders and recognized for being at the forefront of diabetes prevention, treatment, and research. Patients benefit from a team approach to care and ongoing research that has earned us national recognition as a leader in treating children with diabetes and other endocrine and metabolic disorders. Read more about our faculty and staff.

The Division of Pediatric Endocrinology and Diabetes is committed to providing patients the best medical care possible. This commitment goes hand in hand with our dedication to discovering and pioneering the latest treatment methods through ongoing clinical research. Our research areas include a vast range of topics associated with endocrinology, including diabetes, growth and growth hormone.

Our research team is collaborating with the Center for Pediatric Genomic Medicine at Children's Mercy to help diagnose pediatric conditions at the genetic level.Using STAT-Seq, the Genome Center helped endocrinologists diagnose the specific type of hyperinsulinism affecting a critically ill newborn. In one weekend, the diagnosis was made and surgery targeting the specific genetics of the patients condition was conducted. In the past, endocrinologists would have been limited to testing that only sequenced a handful of genes.

Continue reading here:
Children's Mercy Kansas City - Pediatric Endocrinology and ...

Sports medicine is the study and practice of medical principles related to the science of sports, particularly in the areas of:

What is a Sports Medicine Specialist? A sports medicine specialist is an individual with specialized education and training who focuses on the medical and therapeutic aspects of sports participation and physical activity.

This title of sports medicine specialist does not necessarily mean the specialist is a physician. There are bachelors, masters, and certificate programs in sports medicine.

What is a Sports Medicine Physician?

Sports medicine physicians have specialized training in the field in medicine that deals with sport or exercise-related injuries. Their primary focus is on the diagnosis, treatment and prevention of injuries that occur during sports and other physical activity.

A sports medicine physician receives special training during a fellowship program in sports medicine after finishing a residency program in another specialty, such as primary care or orthopedic surgery. There are currently no widespread residency programs in sports medicine.

Most primary care sports medicine doctors complete a three-year family medicine residency after medical school, and then choose to focus on sports medicine.

An orthopedic surgery residency leads to a career as an orthopedic surgeon, many of who treat athletes.

What is Sports Science? Sports science, also referred to as exercise science, is a focused study and application of the principals of physiology, anatomy, and psychology as they relate to human movement and physical activity.

Exercise science is still quite young, and much of the field is focused on conducting research on the various adaptations to exercise or the lack of exercise, of the human body. This work ranges from the elite athlete to the general population; children to elderly; and the physical components of fitness to the psychological.

Careers in Sports Medicine and Sports Science There are many career and job opportunities in fields related to sports medicine. Typically, employment opportunities involve working with generally healthy or active people in two major areas:

Lifestyle improvement or performance enhancement

Injury prevention or recovery.

The goal of sports medicine professionals is to help individuals achieve optimal health and performance goals. Those pursuing degrees in sport medicine or sports science, often work in clinical, academic or service employment. Professions include trainers, coaches, researchers, nutritionists, sports psychologists, nutritionists and many others.

Sports Medicine Programs Schools are beginning to offer more and more Sports Medicine and Sports Science curriculum.

Only a few years ago, you would be hard-pressed to find much selection if you wanted to study sports medicine in college. The standard education program consisted of physical education or medical school. Now departments with degree programs specific to sports medicine, athletic training, exercise science, health promotion, kinesiology, sports coaching and a variety of other disciplines are popping up at nearly every university. The choice is yours.

Sports Psychology Programs Sports psychology is a growing profession and many athletes seek the services of psychologists, trainers and coaches who can help them with the mental aspects of sports training. Elite athletes, professionals and Olympians all have tremendous physical skills and research is finding that at these levels mental training skills (focus, relaxation, goal-setting and reducing anxiety) are critical in separating first from second place.

Certified Athletic Trainer (ATC) Programs An athletic trainer is a highly skilled professional who has education and training in athletic health care. To become certified ATC one must pass an examination that covers a variety of topics within the six domains of athletic training including:

Prevention of athletic injuries

Recognition, evaluation and immediate care of athletic injuries

Rehabilitation and reconditioning of athletic injuries

Health care administration

Professional development and responsibility

Once athletic trainers pass the certification examination they can use the designation ATC.

2016 About.com All rights reserved.

Visit link:
Sports Medicine: Who Should You See for a Sports Injury

This portion of the page requires Javascript, which is either disabled in your browser or not supported.

Topics and Services

Information regarding veterinary care, preventive medicine, and public health...

Information on the status, trends, and factors that determine the health and fitness of the U.S. Army...

Information pertinent to maintaining and improving environmental health on installations and in deployment locations...

Health promotion information, products, and services that promote the physical, mental, spiritual, emotional and sexual health...

Information on diseases and conditions of medical importance to the Army population including...

Information on laboratory science and toxicology services as part of the occupational and environmental health assessment...

Information on how to prepare for and respond to public health emergencies: man-made, CBRNE incidents and...

Information that is specific to PHC regions and the services provided...

Information regarding food and drinking water safety and defense for the U.S. Army and other DoD customers...

Information on issues of industrial hygiene and occupational medicine including hearing conservation...

More:
Home - Army Public Health Center

I have some exciting news to share with you! Beginning this year, I have started to expand my practice and operate in partnership with PALM Health. For the next eight weeks, we will continue to provide services under our same model at Preventive Medicines current location on Schuetz Road. We will also be offering new services from our current providers at our new site.

Sometime in the early second quarter of 2016, we will b...e moving to PALM Health, which is a beautiful new integrative medicine and wellness center at 9160 Clayton Road (formerly the location of Buschs Grove restaurant).

During our years together, Ive been on a professional quest to find the best clinical model to serve your needs, and I am happy to announce that I have found this model with PALM. I am personally thrilled to combine forces with a group of esteemed and like-minded colleagues so that we can provide truly integrated care for you under one roof. Many of you have entrusted your family and friends to our care over the past fifteen years, and it has been my honor and joy to provide your medical care at Preventive Medicine. I hope youll join me in transitioning to PALM Health.

Come join us for a tour of our new facility!

Please choose from a selection of Open House dates:

Thursday, February 25th 5:30-7:30 pm

Saturday, February 27th 1-3pm

Tuesday, March 1st 4-6pm

Saturday, March 5th 11-1 pm

Monday, March 7th 5:30-7:30 pm

Thursday, March 10th 4-6 pm

RSVP to Andrew Davitz atl adavitz@palmhealth.com or call 314 373 4183

Read the original here:
Preventive Medicine - facebook.com

Edit Storyline

BJ is appalled when his patient has entry wounds entering his body from 3 different directions. Col. Potter reminds him of Lt. Col. Lacy, 163rd Combat Infantry, the CO with the highest casualty rate of any single battalion in the sector. Apparently, Lacy refused to obey an order to retreat and subjected his men to hell. Poor Klinger: he has tried chicanery, malingering and endless flim-flammery, but now, Klinger is pulling out the heavy artillery, voodoo, to get his Section 8. Lacy visits the Post Op and one of his own men, Corporal North, turns away. Margaret is intrigued with the virile Lacy until she lunches with him and Lacy tells Margaret of his latest plan to take Hill 403. His plan is based on a plan used in the WWII Battle of Monte Casino...and it has a 20-30% casualty rate. Margaret understands this translates to 100 men and she leaves the table, sick. BJ and Hawkeye despise Lacy and his hypocracy; he thrives on his war games. Potter writes an unprecedented letter to I Corp ... Written by LA-Lawyer

See the original post here:
"M*A*S*H" Preventative Medicine (TV Episode 1979) - IMDb